Statistics

Total Visits

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.16

Select a period of time:

Number of views in the range

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.10

Views

Views
May 20242
June 20240
July 20241
August 20241
September 20244
October 20240
November 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom3
 

Top cities views

Views
Fort Worth1